{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Kim D"],"funding":["NHLBI NIH HHS","Foundation for the National Institutes of Health"],"pagination":["2652-2661"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12810971"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["53(4)"],"pubmed_abstract":["<h4>Purpose</h4>Myocardial perfusion imaging (MPI) is frequently used to improve cardiac risk prediction in patients undergoing non-cardiac surgery. However, the data supporting this practice is derived from single center studies and predates current therapy for coronary artery disease (CAD). We evaluated the association between pre-operative testing indication and outcomes as well as predictors of death or myocardial infarction (MI) in these patients.<h4>Methods</h4>We include patients from the international, multicenter REFINE-SPECT registry (13 sites). Based on referral indication, patients were classified as pre-operative testing indications and non-pre-operative testing. We evaluated the associations between pre-operative testing and incidence of death or MI. We then evaluated associa"],"journal":["European journal of nuclear medicine and molecular imaging"],"pubmed_title":["Risk stratification with pre-operative myocardial perfusion imaging."],"pmcid":["PMC12810971"],"funding_grant_id":["R35HL161195","R35 HL161195","R01HL089765","R01 HL089765"],"pubmed_authors":["Halcox J","Kim D","Di Carli MF","Miller RJH","Sharir T","Sinusas AJ","Hauser MT","Bateman TM","Ruddy TD","Berman DS","Dey D","Einstein AJ","Dorbala S","Kaufmann PA","Fish MB","Acampa W","Builoff V","Miller EJ","Slomka PJ"],"additional_accession":[]},"is_claimable":false,"name":"Risk stratification with pre-operative myocardial perfusion imaging.","description":"<h4>Purpose</h4>Myocardial perfusion imaging (MPI) is frequently used to improve cardiac risk prediction in patients undergoing non-cardiac surgery. However, the data supporting this practice is derived from single center studies and predates current therapy for coronary artery disease (CAD). We evaluated the association between pre-operative testing indication and outcomes as well as predictors of death or myocardial infarction (MI) in these patients.<h4>Methods</h4>We include patients from the international, multicenter REFINE-SPECT registry (13 sites). Based on referral indication, patients were classified as pre-operative testing indications and non-pre-operative testing. We evaluated the associations between pre-operative testing and incidence of death or MI. We then evaluated associa","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Mar","modification":"2026-07-16T09:42:19.337Z","creation":"2026-07-09T10:46:52.39Z"},"accession":"S-EPMC12810971","cross_references":{"pubmed":["41143983"],"doi":["10.1007/s00259-025-07530-6"]}}